Mathilde Figon "More data, less drama"

This #Worldenviromentalday we are happy to share more progress, on top of our multiple countries B-Corp certified, where we are making tangible impact. Sustainability is a key priority for Sanofi Consumer Healthcare in our goal to be “The best FMCH in the world and for the world”. One area we are focusing on is the production, use and lifecycle of our Point of Sale Materials (POSM). Our partnership with HH Global has given us the platform to properly drive sustainable choices for our POSM with already some strong results in print reduction, the use of recycled material and overall material reduction. For example, at the end of 2023 we recorded a 35% reduction in our printed material tonnage vs our 2021 baseline. We have decided to ramp this up with a co-led program with HH Global with clear external commitments on responsible and diverse sourcing, sustainable material use and a strong overall CO2 footprint reduction. We are committed to making sure that Sanofi Consumer Healthcare leads in POSM sustainability and are proud of our partnership with HH Global to ensure we get there together. Kudos to Marie-Pierre Goyonetche who has been leading this program with our Procurement team and all our country and customer partnership teams for executing. The video below explains the concrete actions we are taking to meet our sustainability goals. #HealthinyourHands #sustainability https://lnkd.in/dUWp4_Mv

122

4 Comments

Do you know Dave Ford ? I first met him about 20 years ago when I was at Sanofi. It was a time, on reflection, filled with incredible talented people, people who have proven over years how outstanding they are. It was a powerful, important time in my career, when I learned quickly and when I was given opportunities to stretch myself by people who were courageous enough to let me have a go and who were confident that talent and hard work were more important than experience. For fun, I found a photo from back in those days - looking fresh faced! I remember when David was a new HR Director talking about the new car policy - something very important to the sales team!! He talked about the new flexible policy where options were allowed - you could bespoke your car - life changing for some people at that time - but David gave a condition - “Except if you want to add a whales tail fin to the back!” It summed him up. He knew the audience, he was humourous, fun, but also very strategic about his thinking. I was immediately impressed. I knew that when we decided to run a series on The Commercial Edge Podcast on difficult conversations I wanted David to join the conversation. We have stayed in touch over the years through social media and he was generous enough to debut his podcast career with us. He didn’t disappoint! We talked company values, communicating change, consistency in messages, honesty and transparency. It is a typical David discussion, smart, considered, strategic - all the reasons why he continues to shape businesses for the better. Have a listen on Spotify, Apple Podcasts, Podbean or where you get your podcasts. https://lnkd.in/eYpY4QB7

90

37 Comments

"Believe in yourself and dare." These are the words of Hamza Laajaj, @Sanofi’s Manufacturing 4.0 Booster Leader at our Neuville site (France), and a motto we collectively share. At Sanofi, when it comes to manufacturing vaccines to improve people’s lives, we embrace diversity through the roles we play, the projects we work on, and the teams we work with. By being open to diversity, we unlock innovation. Learn more about how Hamza is fueled by collective energy to lead manufacturing innovation in our pursuit of progress. #PursueProgress #Science #Diversity

12

Catching the direct #TGV from #Brussels to #Lyon with Olivier Reynaert Reviewing our Europe strategy at 300km/h and realizing we need to accelerate even more. We're hungry for growth, maybe even dreaming big. But our capability and capacity are expanding, thanks to our visionary consultants, amazing clients, and the incredible support from our team. Let's keep pushing the boundaries. 🚄💼🚀 P.S. Interested in Pharma digitalisation and CQV project management? Let's connect and discuss how we can innovate together! #Pharma #Digitalisation #CQV #ProjectManagement #Innovation #TGV #BusinessGrowth If you found this interesting, consider resharing ♻️ and follow No deviation for more updates.

59

2 Comments

Great work Laura Heinrich and Pratyush Sharma ! Through the standardization, governance, and sharing of health data, we can significantly enhance healthcare delivery, improve patient outcomes, and ultimately reduce global mortality rates. As part of Capgemini ‘s ongoing collaboration with the World Economic Forum (#WEF) via the Digital Healthcare Transformation initiative, we are working alongside global partners to shape the future of healthcare. Our latest blog highlights how digital health data collaboration is key to: Overcoming fragmented healthcare systems to create an integrated, patient-centered approach. Improving diagnostics, treatment, and prevention while reducing medical errors. Detecting chronic conditions early and reducing complications in maternal health, advancing Sustainable Development Goal 3 (SDG3). Leveraging non-clinical data like weather patterns to predict and prevent public health crises, such as outbreaks of water-borne diseases. Fostering a cultural shift towards trust in data sharing and collaboration, ensuring data is used ethically and efficiently. We invite you to read this impactful blog and join the conversation on how we can transform healthcare through data collaboration. #HealthcareInnovation #DataCollaboration #WEF #SDG3 #DigitalHealth #GlobalHealth

13

1 Comment

We’ve been talking about digital health developments and innovation for some time in Wavestone, so really pleased to see Rachael M., Philip W. and Alex Miller’s insights on the #DigitalHealth space in Europe with the launch of our first Digital Health Radar, available here: https://lnkd.in/gRXuF2t5   The Radar highlights 17 interesting startups in the European digital health startups landscape. They provide food for thought on some emerging market characteristics, including the importance of: -The right information -Patient-centered care -End-to-end patient journey -Evidence-based solutions

34

1 Comment

My thoughts on some Supply Chain Management topics in a recent interview with Cold Chain Platform (CCP), in collaboration with LogiPharma Asia

34

1 Comment

« In a world with increasing geopolitical tensions, we need to make sure that patients can get access to the treatments they need » one of the many reflections shared by our CEO Christophe Weber during his interview in « Les Echos ». He outlines the need for pharmaceutical companies to have scale and be global, how he transformed Takeda over the last decade, how exciting scientific and digital progress will impact health care systems. Health care systems in which Takeda wants to partner with all parties involved to ensure they stay sustainable. An ambition everyone in Takeda contributes to, to ensure a better health and a brighter future.

93

When you apply cosmetics or add product to your hair in the morning, are you thinking about the environment? I'm for one am still drinking my morning coffee so sustainability is probably not the first thing on my mind as my mascara goes on! But thankfully L'Oréal is prioritizing sustainability from the earliest stages of innovation with the help of technology. Curious about how L'Oréal is revolutionizing beauty with Digital Innovation? Check out my team's latest video, where Matthieu Cassier dives into: ✨ Leveraging digital platforms for seamless collaboration 🌱 Pioneering green sciences and personalized beauty 🚀 Grounding innovation in structured, science-backed data Don’t miss out on these insights into how L'Oréal is leading the way in sustainable, tailor-made beauty solutions and how Veeva Consumer Products helped. Watch now to see digital transformation in action. #DigitalInnovation #Sustainability #BeautyTech #ProductDevelopment #AI #GreenSciences #Transformation #LOréal

4

#Hypertension is a silent disease affecting millions worldwide. After the World Hypertension Day earlier this month, I wanted to emphasize the importance of awareness and action in combating this global health issue. At Servier, we are committed to advancing the prevention, diagnosis, and treatment of hypertension. For the past seven years, we have been dedicated to enhancing hypertension screening through our #BecauseISaySo global awareness campaign. This initiative aims to provide patients with the necessary information and tools to make regular blood pressure monitoring a habitual practice. Together, we can make a significant impact on reducing the burden of hypertension. #BeTheCaptainOfYourLife by #CheckYourBloodPressure regularly 💪 #BecauseIsayso Corina Jarquin Chems Eddine DJEGHLAL Liliana Alvarado Arévalo Michael van der Walt Caroline GIACOMONI (BELLAICHE) Anne VENOT Learn more here: https://lnkd.in/em5W7qBP

74

Hear the thoughts of our CEO - Fabrice Chartier, on finding the right CRO that aligns to your values

15

1 Comment

It is a proven fact that All companies that have set #OperationalExcellence# (OpEx) Capabilities in their organization have a competitive advantage if they are able to - install the right culture - set strong awareness of the need for continuous improvement. With the right #lean6sigma# expert and when the culture is set, those companies are #Agile# - They continuously adapt versus customer need. - Their processes are lean and robust, with the right level of Quality - They make #RiskManagement# and NOT Risk Avoidance Last, but not least, in case of issue or burning platform, the 6-sigma approach ensure quick troubleshooting to get back to performant processes. The OSICS Network proposes to help companies to get staffed/supported with the right people that will bring them to successful implementation of an Agile company with high #CustomerSatisfaction" Have a look at the offer described by Fabrice Le Garrec and Pascale Liroy

9

Think patient experience does not have an impact? Think again. ''The perception of the pharma industry’s reputation among respondent US patient groups declined in 2023, with 57% rating the industry’s reputation as “Excellent” or “Good”, compared with 65% saying the same in 2022.'' ...sharp declines were reported by respondent US patient groups for: • the quality of pharma’s patient-group relations; • its provision of patient information; and • its ability to improve access to medicines. I would put this in a large bucket called 'Experience'. Magnus Franzén-Rossi would welcome your thoughts as you have spent a lot of time in this space; improving organisational ability to deliver improved patient experience, and quantifying impact. https://lnkd.in/ekZvtp_U

30

2 Comments

Did you ever reach Friday with a feeling that you don't quite want the working week to stop? You think I'm crazy....! Let me explain... This week I had the privilege to meet with clients and our expert teams to discuss the following projects (in no particular order): - A novel ADC candidate undergoing first in human trials in patients with advanced cancer - A gene therapy product targeting a single rare mutation leading to a variety of serious outcomes in children, which is ready for the clinic for the first time - A new injectable product focussed on making IVF cycles more convenient and hopefully more effective - An AI-based bedside imaging tool for use in emergency medicine with potential to improve diagnosis and therefore urgent care - A trial aimed at breathing new life into an often overlooked but effective therapy used in psychiatry - A simple OTC product which may help children avoid seasonal colds Perhaps now you may understand why I can't wait to see what next week will bring! ClinChoice

63

8 Comments

Interested in making sure your health blog writing and SEO research skills are at their best (in English and/or in French)? I have one slot left to welcome a new mentee with 1:1 sessions in November. Here's some more info about the 1:1 mentoring programme and what is included (basically, everything I wish I had when I started): - 2 x 1 hour live sessions with me - you have flexibility to book sessions based on your schedule but I'd recommend having at least 1 or 2 weeks in between to give you time for the exercises, self-reading and digesting everything. - SEO blog template and checklist tools - Access to presentations and video materials focusing on SEO health blog writing - Access to my previous mentees and community for freelance tips and experience sharing with people having a similar background to you - Full blog assignment with my support (topic & timeline to be decided before we start. Typically we try to do draft submission + edits within 1 week so that editors can manage their workload). The copy editor I'm currently working with is our RN health writer Maggie Aime, MSN, RN from the US - Practical exercises and email support in between live sessions, and for up to 3 months after the programme. (I'm saying 3 months as I'm hoping you can secure a real blog assignment during that time, not to forget your learnings!) In practice, I remain available for my mentees when they have a real-life blog assignment. Current rate: US $500 (Preferential rates apply to developing countries). If you'd like to be considered but do not have the time or budget right now, drop me a message and I'll share some free info and resources to get you started with SEO health blog writing. Let's get you ready for 2025 ! Val ✍️ PS: thank you Mónica Faut, Ph.D. for sharing her feedback. -- Hi, I'm Val 👋 ✍️ I help B2C & B2B health businesses improve their credibility and visibility on Google. Every blog is unique, infused with genuine empathy and scientific expertise. 📚 I support health and medical writers worldwide to upgrade their services with monthly top-notch SEO blogs.

11

4 Comments

In the pharmaceutical sector, major acquisitions are the trend. The value of deals increased by 38% in 2023, with a marked interest in therapeutic areas such as oncology and rare diseases, as well as data-driven and AI solutions. This shift in deals comes with added complexity due to financial weight, integrating new expertise, and strengthened regulatory environments across all markets. It is crucial not only to confirm regulatory suitability, such as the quality of existing dossiers to avoid costly market maintenance for established products, the relevance of data for unmet medical needs, and the quality of CMC aspects (e.g., cell and gene therapies needing enhanced CMC sections despite clinical efficacy), but also to assess challenges in transitioning medical devices from MDD to MDR. At PLG, we offer these services combined with access and adoption due diligence, providing significant added value as regulatory challenges are intrinsically linked to the markets served #PLC #duediligenceservice #riskfreeenvironment https://lnkd.in/eu2ViGx8.

9

From 6 to 9 June, we await an important date with the #EuropeanElections, where the 720 members of the Parliament will be elected. An event of vital importance for the citizens of the European Union, where they will be able to take part in the crucial decisions for the future of the continent.    The world needs a stronger and more united Europe and, at Merck Healthcare, we want to contribute to its economic and social empowerment through science, technology, and sustainability. To achieve this, we must ensure Merck in Europe has a much stronger, consistent, and more united voice for the world.   We face several challenges and priority areas on the EU policy agenda where we have the opportunity to position itself as part of the solution. In addition, the connection between Merck and Europe is getting stronger through our 28,000 employees dedicated to driving innovation with our headquarters in the heart of the continent.   It is #TimeToVote to reaffirm our role in the future and ensure a more united and global Europe.   #FromEuropeToGlobal  #MerckEU  

138

Future Pharma Companies will be Data Science Companies that also sell medicine Sanofi's €400 million investment to expand its Global Capability Centre (GCC) in Hyderabad, India, highlights the increasing importance of data and technology in the pharmaceutical industry. By onboarding talent at the Hyderabad hub to embrace the power of AI, Sanofi is positioning itself as a data-driven company that also sells medicines Sanofi's ambition to be the "first biopharma company powered by Artificial Intelligence (AI) at scale" suggests that future pharmaceutical companies will need to embrace data and technology to remain competitive

30

6 Comments